Open Access Publishing in Genetics and Molecular Biology Is the Highway to Biomedical Applications
SINGAPORE and LONDON (PRWEB) October 30, 2018 -- Growth, development, reproduction as well as susceptibility and immunity to diseases are direct manifestations of genetic architecture and molecular functioning in a biological organism. Genetic sequences are subject to change owing to multitude of factors including environment, resulting in varied phenotype. Subcellular characterization of biological events has rendered the present day genetics and molecular biology, a vast and complex subject. Almost about one tenth of global research focusses on this domain of science. Consistent increase in the demand for molecular biology kits and reagents over the recent years reflects the increasing research activities among which, research based on polymerase chain reaction (PCR) and genetic sequencing constituted substantial proportion. As a result, genetic applications including gene therapy are projected to have significant impact on a medical science in the near future.
A large volume of information is being generated as a result of widening research activities. The information needs to be effectively broadcasted for enabling integration and development of application-oriented technologies. Open access mode of publishing, by the virtue of its seamless access and wider critical evaluation yields unbiased assessment of research progress and leads the most appropriate research direction. It facilitates a coordinated and collaborative research effort on a global scale which is essential for dispensing redundant research activities and promoting targeted approach. Open science has the potential to maximize the genetic and molecular biology research outcomes and has greater impact in translation of academic research into different utilities.
The theme of Open Access Week 2018 “Designing Equitable Foundations for Open Knowledge,” emphasizes on devising open science strategy which is equitable and effectively serves diverse communities. On this occasion, Dr. Srinibabu Gedela, Founder & CEO, Omics International, has expressed his opinion that open access scientific publication can be potentially translated into multiple regional languages without copyright restrictions thus rendering the information more accessible and affordable by populations inhabiting even in the remotest corners. He has emphasized that removal of language and technical barriers is essential for articulating knowledge for societal benefit.
Omics International is one of the leading publishers with more than 1000 open access journals in science and management crossing the overall readership by 50 million in the year 2018 and is an ardent follower of open science policy right from its inception in the year 2007. Omics publishes about 58 open access journals related to genetics and molecular biology.
On the occasion of this global event, the scientific contributors were encouraged to tag their submission with Open Access Week 2018 theme to mark their support for the open access movement and were invited to provide their valuable inputs on removing potential inequalities and addressing the needs of publishing stakeholders while implementing open access policy. In order to promote the awareness of open access, Omics provided special recognition to its authors and minimize the processing charges for students and early career scholars, and ensured that the spirit of the open access movement survived in its celebration of the event.
Abhishek Babu, PULSUS GROUP, http://www.pulsus.com, +91 4047482201, [email protected]
Share this article